The fund is driven by ”la Caixa” and the Centro para el Desarrollo Tecnológico Industrial (Centre for Industrial Technological Development, CDTI) under the framework of the Innvierte Programme an...
The proceeds will support the development of the HTI immunogen as a therapeutic vaccine against HIV infection, up to the completion of a Phase 2 proof-of-concept efficacy trial in HIV-infected individ...
Transplant Biomedicals está desarrollando una innovadora y singular tecnología que previene las lesiones que tiene lugar durante el transporte de los órganos que se van a someter a trasplante, ya q...
Ysios Capital, a Spanish investment fund, led the round. The fundraising was also supported by a substantial syndicate of new investors including Kurma Partners, Roche Venture Fund, Idinvest Partners ...
Financing will advance Sanifit’s lead drug candidate through phase IIb as a treatment for cardiovascular diseases linked to calcification and through phase II/III for calciphylaxis
En esta primera edición se destinarán 840.000 euros para la financiación de 15 proyectos, mientras que la formación que se brinda se ha valorado en otros 225.000 euros